Nucleic acid-based Molecular diagnostic testing of SARS-CoV-2 with self-collected saliva specimens
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Since the outbreak of coronavirus disease 2019 (COVID-2019), the infection has spread worldwide due to the highly contagious nature of severe acute syndrome coronavirus (SARS-CoV-2). To manage SARS-CoV-2, the development of diagnostic assays that can quickly and accurately identify the disease in patients is necessary. Currently, nucleic acid-based testing and serology-based testing are two widely used approaches. Of these, nucleic acid-based testing with quantitative reverse transcription-PCR (RT-qPCR) using nasopharyngeal (NP) and/or oropharyngeal (OP) swabs is considered to be the gold standard. Recently, the use of saliva samples has been considered as an alternative method of sample collection. Compared to the NP and OP swab methods, saliva specimens have several advantages. Saliva specimens are easier to collect. Self-collection of saliva specimens can reduce the risk of infection to healthcare providers and reduce sample collection time and cost. Until recently, the sensitivity and accuracy of the data obtained using saliva specimens for SARS-CoV-2 detection was controversial. However, recent clinical research has found that sensitive and reliable data can be obtained from saliva specimens using RT-qPCR, with approximately 81% to 95% correspondence with the data obtained from NP and OP swabs. These data suggest that self-collected saliva is an alternative option for the diagnosis of COVID-19.
Abstract
Since the outbreak of coronavirus disease 2019 (COVID-2019), the infection has spread worldwide due to the highly contagious nature of severe acute syndrome coronavirus (SARS-CoV-2). To manage SARS-CoV-2, the development of diagnostic assays that can quickly and accurately identify the disease in patients is necessary. Currently, nucleic acid-based testing and serology-based testing are two widely used approaches. Of these, nucleic acid-based testing with quantitative reverse transcription-PCR (RT-qPCR) using nasopharyngeal (NP) and/or oropharyngeal (OP) swabs is considered to be the gold standard. Recently, the use of saliva samples has been considered as an alternative method of sample collection. Compared to the NP and OP swab methods, saliva specimens have several advantages. Saliva specimens are easier to collect. Self-collection of saliva specimens can reduce the risk of infection to healthcare providers and reduce sample collection time and cost. Until recently, the sensitivity and accuracy of the data obtained using saliva specimens for SARS-CoV-2 detection was controversial. However, recent clinical research has found that sensitive and reliable data can be obtained from saliva specimens using RT-qPCR, with approximately 81% to 95% correspondence with the data obtained from NP and OP swabs. These data suggest that self-collected saliva is an alternative option for the diagnosis of COVID-19.
참고문헌 (26)
- Wu F, "A new coronavirus associated with human respiratory disease in China", Nature, 579, pp.265~269 (2020)[DOI]
- Esbin MN, "Overcoming the bottleneck to widespread testing : a rapid review of nucleic acid testing approaches for COVID-19 detection", RNA, 26, pp.771~783 (2020)[DOI]
- Chan JF, "Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp", Hel real-time reverse transcription-PCR assay validated in vitro and with clinical specimens, 2020, pp.58, e00310~e00320
- Feng W, "Molecular diagnosis of COVID-19: challenges and research needs", Anal Chem, 92, pp.10196~10209 (2020)[DOI]
- Behera BC, "Recent biotechnological tools for diagnosis of corona virus disease : a review", Biotechnol Prog, 37, pp.e3078~ (2021)[DOI]
- Cobb B, "The cobas® 6800", 8800 System : a new era of automation in molecular diagnostics, 2017, pp.17, 167~180
- Sethuraman N, "Interpreting diagnostic tests for SARS-CoV-2", JAMA, 323, pp.2249~2251 (2020)[DOI]
- Yu L, "Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification(RT-LAMP)diagnostic platform", Clin Chem, 66, pp.975~977 (2020)[DOI]
- Wölfel R, "Virological assessment of hospitalized patients with COVID-2019", Nature, 581, pp.465~469 (2020)[DOI]
- Wang Y, "Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak", J Med Virol, 92, pp.538~539 (2020)[DOI]
- Kudo E, "Detection of SARS-CoV-2 RNA by multiplex RT-qPCR", PLoS Biol, 18, pp.e3000867~ (2020)[DOI]
- Alcoba-Florez J, "Sensitivity of different RT-qPCR solutions for SARS-CoV-2detection", Int J Infect Dis, 99, pp.190~192 (2020)[DOI]
- Vogels CBF, "Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets", Nat Microbiol, 5, pp.1299~1305 (2020)[DOI]
- Udugama B, "Diagnosing COVID-19 : the disease and tools for detection", ACS Nano, 14, pp.3822~3835 (2020)[DOI]
- Bwire GM, "Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens : a systematic review and meta-analysis", J Med Virol, 93, pp.719~725 (2021)[DOI]
- Wang W, "Detection of SARS-CoV-2 in different types of clinical specimens", JAMA, 323, pp.1843~1844 (2020)[DOI]
- Azzi L, "Saliva is a reliable tool to detect SARS-CoV-2", J Infect, 81, pp.e45~50 (2020)[DOI]
- Azzi L, "Diagnostic salivary tests for SARSCoV-2", J Dent Res, 100, pp.115~123 (2021)[DOI]
- McCormick-Baw C, "Saliva as an alternate specimen source for detection of SARS-CoV-2 in symptomatic patients using Cepheid Xpert Xpress SARS-CoV-2", J Clin Microbiol, 58, pp.e01109~20 (2020)[DOI]
- Nagura-Ikeda M, "Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR(RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19", J Clin Microbiol, 58, pp.e01438~e01520 (2020)[DOI]
- To KKW, "Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay : a diagnostic validity study", Clin Microbiol Infect, 25, pp.372~378 (2019)[DOI]
- Pasomsub E, "Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019 : a cross-sectional study", Clin Microbiol Infect, 27, pp.285.e1~285.e4 (2021)[DOI]
- Chojnowska S, "Human saliva as a diagnostic material", Adv Med Sci, 63, pp.185~191 (2018)[DOI]
- To KK, "Consistent detection of 2019 novel coronavirus in saliva", Clin Infect Dis, 71, pp.841~843 (2020)[DOI]
- Migueres M, "Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers", J Clin Virol, 130, pp.104580~ (2020)[DOI]
- Wyllie AL, "Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2", N Engl J Med, 383, pp.1283~1286 (2020)[DOI]